May Measurement Month 2017: an analysis of blood pressure screening results from the United Kingdom and the Republic of Ireland—Europe
Brady, Adrian J.B.
Schtte, Alta E.
Poulter, Neil R.
Cappuccio, Francesco P.
Oxford University Press
MetadataShow full item record
Elevated blood pressure (BP), or hypertension, is a growing burden worldwide, leading to over 10 million deaths each year. May Measurement Month (MMM) is a global initiative aimed at raising awareness of high BP and acting as a stimulus to improving screening programmes worldwide. In the United Kingdom (UK) nearly 1 in 5 people, and in the Republic of Ireland (RoI) 3 out of 10, have hypertension, of which a large proportion remains undiagnosed. An opportunistic cross-sectional survey of volunteers aged ≥18 years was carried out in May 2017. Blood pressure measurement, the definition of hypertension and statistical analysis followed a standardized protocol. Screenings sites in hospitals, universities, shopping centres, workplaces, sports clubs, community centres, GP practices, and pharmacies were set up across the UK and RoI as part of this initiative. Seven thousand seven hundred and fourteen individuals were screened during MMM17. After multiple imputation, 3099 (40.3%) had hypertension. Of individuals not receiving antihypertensive medication, 1406 (23.4%) were hypertensive. Of individuals receiving antihypertensive medication, 682 (40.5%) had uncontrolled BP. MMM17 was the largest BP screening campaign ever undertaken in the UK and RoI. These data prove for the first time that a relatively inexpensive, volunteer based, convenience sampling of screening BP in the community identified two out of five individuals as hypertensive, with one in four not receiving treatment. Of major concern is that these data demonstrate that of those individuals receiving treatment, two out of five still did not have controlled BP.
European Heart Journal Supplements;
McDonnell, B.J., Keitley, J., Beaney, T., Tay, T., Brady, A.J.B., Padmanabhan, S., Cockcroft, J.R., Dolan, E., Heagerty, A., Greenstein, A., Tomaszewski, M., Schutte, A.E., Poulter, N.R. and Cappuccio, F.P. (2019) 'May Measurement Month 2017: an analysis of blood pressure screening results from the United Kingdom and the Republic of Ireland—Europe', European Heart Journal Supplements, Volume 21, Issue Supplement_D, pp. D121–D123. DOI: 10.1093/eurheartj/suz072.
Article published in European Heart Journal Supplements on 24 April 2019, available open access at: https://doi.org/10.1093/eurheartj/suz072.
Cardiff Metropolitan University (Grant ID: Cardiff Metropolian (Internal))
Showing items related by title, author, subject and abstract.
May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension Beaney, T.; Burrell, L.M.; Castillo, R.R.; Charchar, F.J.; Cro, S.; Damasceno, A.; Kruger, R.; Nilsson, P.M.; Prabhakaran, D.; Ramirez, A.J.; Schlaich, M.P.; Schutte, A.; Tomaszewski, M.; Touyz, R.; Wang, J.-G.; Weber, M.; Poulter, N.; the MMM Investigators; McDonnell, Barry (Oxford University Press, 2019-05-01)Aims Raised blood pressure (BP) is the biggest contributor to mortality and disease burden worldwide and fewer than half of those with hypertension are aware of it. May Measurement Month (MMM) is a global campaign set up ...
Beaney, T.; Schutte, A.E.; Tomaszewski, M.; Ariti, C.; Burrell, L.M.; Castillo, R.R.; Charchar, F.J.; Damasceno, A.; Kruger, R.; Lackland, D.T.; Nilsson, P.M.; MMM Investigators; McDonnell, Barry (Elsevier, 2018-05-16)Background Increased blood pressure is the biggest contributor to the global burden of disease and mortality. Data suggest that less than half of the population with hypertension is aware of it. May Measurement Month was ...
Prevalence of metabolic risk factors and associated 10‐year prediction of cardiovascular disease and diabetes in female employees Gray, B.; Bracken, R.; Turner, D.; Morgan, K.; Mellalieu, Stephen D.; Thomas, M.; Williams, Sally P.; Williams, M.; Rice, S.; Stephens, J.W. (Wiley, 2014-09-08)Cardiovascular disease (CVD) and type 2 diabetes (T2DM) remain two of the greatest health challenges in the United Kingdom. Guidelines currently advocate screening individuals to identify those at ‘high risk’ (10‐year risk ...